Oncology Brothers: Practice-Changing Cancer Discussions

By Oncology Brothers

Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.


Category: Medicine

Open in Apple Podcasts


Open RSS feed


Open Website


Rate for this podcast
    

Subscribers: 8
Reviews: 0
Episodes: 100

Description

The Oncology Brothers Podcast, led by Drs. Rahul and Rohit Gosain, is dedicated to bridging the gap between academic cancer centers and community oncology in the ever-evolving field of hematology & oncology. With a mission to disseminate crucial information to the medical community, this oncology podcast is not for medical advice but rather serves as a beacon for physicians, nurses, trainees, and advanced practice providers (APPs) involved in the care of cancer patients. Drs. Rahul and Rohit Gosain, both esteemed oncologists, bring a wealth of experience and expertise from their general community practice to these discussions. Through short and engaging interviews with world-renowned researchers, clinicians, hematologists, and oncologists, they present practice-changing data in a concise, bite-sized format. Get the latest FDA approvals news, oncology conference highlights, and treatment algorithms in 25 minutes or less. Conversations center around common cancers you see in your clinic like breast cancer, prostate cancer, kidney cancer, bladder cancer, lung cancer, and GI cancers. With new indications and approvals, we talk about how to incorporate this data in your day to day clinical practice. Each episode includes visual presentations so you can follow along within the podcast players and on YouTube @oncbrothers. These visual tools and algorithms will provide an outline on what is covered in each episode. Immediately apply the latest insights and advancements in your daily practice, ensuring the delivery of optimal cancer care to patients within your local communities. If you want to navigate the complexities of your hematology & oncology practice and stay current, the Oncology Brothers Podcast offers invaluable insights and practical takeaways to enhance your professional journey and improve patient outcomes. For more information, please visit: www.oncbrothers.com, and connect with us on Twitter/X/Instagram/TikTok: @oncbrothers, or email us at info@oncbrothers.com

Episode Date
Challenging Cases with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Jul 21, 2025
How to Treat Diffuse Large B-Cell Lymphoma (DLBCL) in 2025
Jul 17, 2025
How to Treat Early Stage Non-Small Cell Lung Cancer in 2025
Jul 10, 2025
ASCO 2025 - GU Cancer Highlights: KEYNOTE-564, AMPLITUDE, ARANOTE, NIAGARA
Jul 04, 2025
FDA Approval of Telisotuzumab (Teliso-V) in c-MET Overexpression - LUMINOSITY trial
Jun 27, 2025
ASCO 2025 - Breast Cancer Highlights: INAVO120, SERENA-6, VERITAC-2, DESTINY-Breast09, ASCENT-04
Jun 20, 2025
ASCO 2025 - GI Cancer Highlights: DYNAMIC III, ATOMIC, BREAKWATER, MATTERHORN, DESTINY Gastric04
Jun 14, 2025
ASCO 2025 Lung Cancer Highlights: CheckMate 816, ToD, NeoADAURA, IMforte, DeLLphi 304
Jun 07, 2025
Nivolumab plus Ipilimumab in Microsatellite-Instability–High (MSI-H) Metastatic Colorectal Cancer
May 26, 2025
Managing Toxicities of EGFR Inhibitors: Afatinib, Amivantamab-Lazertinib, Osimertinib
May 21, 2025
How to treat Small Cell Lung Cancer in 2025
May 19, 2025
Treatment of Metastatic Non-Small Cell Lung Cancer With Targeted Mutations
May 15, 2025
How to Treat Metastatic Non-Small Cell Lung Cancer (NSCLC) Without Targeted Mutations
May 12, 2025
Managing Side Effects of HER2 Targeted Therapy - Zanidatamab & Trastuzumab deruxtecan (T-DXd)
May 08, 2025
Perioperative Durvalumab FDA Approval New Standard for Muscle Invasive Bladder Cancer
May 05, 2025
Treatment Options for HER2 Positive Biliary Tract Cancers
May 01, 2025
The HER2 Diagnostic and Treatment Landscape in NSCLC
Apr 29, 2025
Overview of Biliary Tract Cancer & Importance of Targeted Therapies
Apr 24, 2025
What does it mean to be HER2 Positive in Lung Cancer
Apr 21, 2025
European Lung Cancer Conference (ELCC) 2025 Highlights: KEYNOTE-799, LAURA, MARIPOSA, KRYSTAL-7
Apr 14, 2025
FDA Approval of Cabozantinib - CABINET in pNET and epNET
Apr 10, 2025
How to Manage & Treat Pancreatic Cancer
Apr 07, 2025
How to Treat Upper Gastrointestinal Cancers in 2025 - Treatment Algorithm
Mar 31, 2025
ToxCheck: Managing Side Effects of Pancreatic Cancer Treatment
Mar 27, 2025
Prostate Cancer Management from Early Stage to Advanced Metastatic Disease - Dr. Alan Bryce
Mar 24, 2025
How to Treat Renal Cell Carcinoma (RCC) using a Treatment Algorithm with Dr. Katy Beckermann
Mar 17, 2025
How to Treat Bladder Cancer in 2025 with Dr. Joaquim Bellmunt
Mar 10, 2025
FDA Approval of Tislelizumab - RATIONALE 305 and 306 in Upper GI Cancers
Mar 06, 2025
GU ASCO 2025 Highlights - TALAPRO-2, NIAGARA, CheckMate-9ER, TiNivo-2
Mar 03, 2025
How to Treat Hormone Receptor Positive Cancer - Latest Advancements and Current Standard of Care in 2025
Feb 24, 2025
FDA Approval of Zolbetuximab SPOTLIGHT / GLOW study - Upper GI Cancer with Claudin 18.2 Mutation
Feb 21, 2025
How to Treat HER2+ Breast Cancer - Discussion with Dr. Sarah Sammons
Feb 17, 2025
How to Treat Triple Negative Breast Cancer - Discussion with Dr. Virginia Kaklamani
Feb 10, 2025
GI ASCO 2025 Highlights - BREAKWATER, CheckMate-8HW, ALASCCA, STARTER-NET
Feb 03, 2025
FDA Approval of Subcutaneous Nivolumab CheckMate-67T - Subcutaneous Nivo vs. Intravenous (IV) Nivo
Jan 31, 2025
Intermediate HCC – the evolving role of Immunotherapy with Multimodality approaches
Jan 27, 2025
Managing Side Effects of Anti-VEGF Bevacizumab & Anti-EGFR Cetuximab and Panitumumab
Jan 22, 2025
ASH Lymphoma 2024 Highlights - POLARIX Update, inMIND, TRIANGLE, ENRICH with Dr. Pallawi Torka
Jan 21, 2025
SABCS 2024 Highlights - DESTINY-Breast06, DESTINY-Breast12, PATINA with Dr. Sara Tolaney
Jan 17, 2025
SABCS 2024 Highlights - EUROPA, TAILORx, PADMA, EMBER-3 with Dr. Jame Abraham
Jan 15, 2025
Intermediate Hepatocellular Carcinoma (HCC) – Treatment Options & Strategies
Jan 13, 2025
SABCS 2024 Highlights - INSEMA, KEYNOTE-522, OlympiA
Jan 09, 2025
Multiple Myeloma ASH 2024 Highlights with Dr. Robert Orlowski
Jan 07, 2025
FDA Approval of Zanidatamab - HERIZON-BTC-01 Discussion with Dr. Shubham Pant
Jan 02, 2025
ASH 2024 CLL Highlights - SEQUOIA, AMPLIFY, CELESTIAL, Role of CAR-T Cell Therapy
Dec 26, 2024
CAR-T Toxicity Check: From Approval to Practice, Managing Side Effects of CAR-T Therapy
Dec 21, 2024
Leukemia ASH 2024 Highlights - Menin Inhibitors, CPX 351 vs 7+3, Venetoclax Based Regimens
Dec 19, 2024
2nd line treatment in advanced HCC and when to switch
Dec 13, 2024
From Approval to Practice: Managing Side Effects of Antibody Drug Conjugates (ADC) in Cancer
Dec 02, 2024
The use of Immunotherapy in unresectable Hepatocellular Carcinoma (HCC)
Nov 28, 2024
INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
Nov 25, 2024
How to Approach and Treat Pancreatic Cancer
Nov 21, 2024
Understanding the Impact of Nutrition & Exercise on Cancer Outcomes
Nov 18, 2024
How to Diagnose, Treat, and Follow Neuroendocrine Tumors (NETs)
Nov 14, 2024
Palliative Care Management in Cancer
Nov 08, 2024
How to Approach to Ovarian Cancer from Community Oncology Perspective
Oct 31, 2024
How to Approach to Endometrial Cancer from Community Oncology Perspective
Oct 24, 2024
DeLLphi-301 - FDA Approval of Tarlatamab in Patients w/ Prev Treated Small Cell Lung Cancer (SCLC)
Oct 22, 2024
AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer
Oct 20, 2024
Lung Cancer ESMO 2024 Highlights: Key Studies Discussed LAURA, MARIPOSA, MARIPOSA-2, ADRIATIC
Oct 17, 2024
AGAVE-201 Study - FDA Approval of Axatilimab for Chronic Graft-versus-Host Disease (cGVHD)
Oct 15, 2024
How to Approach to Acute Myeloid Leukemia (AML) from Community Oncology Perspective
Oct 13, 2024
GI Cancer ESMO 2024 Highlights: Key Studies Discussed LEAP-012, KEYNOTE-811, POD1UM-303, NICHE-2
Oct 10, 2024
GU Cancer ESMO 2024 Highlights: Key Studies Discussed NIAGARA, TiNiVO-2, PEACE-3, CONTACT-02
Oct 03, 2024
Breast Cancer ESMO 2024 Highlights: Key Studies Discussed NATALEE, KEYNOTE 522, DESTINY-Breast12
Sep 26, 2024
WCLC 2024 Highlights - Exploring Latest Advances in Lung Cancer Treatment
Sep 19, 2024
How to Treat Chronic Myeloid Leukemia (CML) - Dr. Jorge Cortes
Aug 29, 2024
How to Treat Follicular & Mantle Cell Lymphomas - Discussion with Dr. Pallawi Torka
Aug 22, 2024
How to treat Diffuse Large B-Cell Lymphoma (DLBCL) - Dr. Carla Casulo
Aug 15, 2024
How to treat Cutaneous Melanoma (Skin Cancer) - Dr. Allison Betof Warner
Aug 08, 2024
Role of Cardiology in Cancer Treatment: Cardio-Oncology
Aug 05, 2024
How to Treat Early Stage Non-Small Cell Lung Cancer
Aug 01, 2024
How to Treat Metastatic Non-Small Cell Lung Cancer w/o Targeted Mut in Front-line - Dr. Preeshagul
Jul 25, 2024
How to Treat Non-Small Cell Lung Cancer with Actionable Mutations with Dr. Balazs Halmos
Jul 18, 2024
How to Treat Small Cell Lung Cancer using Treatment Algorithm with Dr. Eric Singhi
Jul 08, 2024
GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis
Jun 24, 2024
GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri
Jun 20, 2024
Breast Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Erika Hamilton
Jun 17, 2024
Lung Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Joshua Sabari
Jun 12, 2024
Multidisciplinary Treatment Approach for Rectal Cancer - Discussion with Drs. Deb Schrag & Krishan Jethwa
May 27, 2024
Zanubrutinib - FDA Approval, Efficacy & Safety Profile in CLL - Discussion with Dr. Shadman
May 23, 2024
How to treat Myelofibrosis - Discussion with Dr. Naveen Pemmaraju
May 20, 2024
Understanding Disparities in Colorectal Cancer Care
May 16, 2024
Relapsed/Refractory Multiple Myeloma Treatment Algorithm with Dr. Samer Al’Hadidi
May 13, 2024
Liver Directed Therapies - Interventional Radiology & Radiation Oncologist Perspective
May 09, 2024
Discussing Treatment Algorithm for Newly Diagnosed Multiple Myeloma with Dr. Caitlin Costello
May 06, 2024
Discussion on Evolving CLL Treatment Strategies with Dr. Nitin Jain
Apr 29, 2024
FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer
Apr 25, 2024
Standard of Care Treatment for Upper GI Cancer: A Discussion with Dr. Sam Clempner
Apr 22, 2024
Standard of Care Treatment for Colon Cancer: A Discussion with Dr. Aparna Parikh
Apr 10, 2024
Unpacking the Treatment Algorithm of Hepatocellular Carcinoma with Dr. Tanios S. Bekaii-saab
Apr 01, 2024
Breakthrough in Bladder Cancer: FDA approval - Enfortumab Vedotin + Pelbrolizumab with Dr. Tom Powles
Mar 27, 2024
Bladder Cancer Treatment Algorithm Discussion with Drs. Karine Tawagi and Sia Daneshmand
Mar 22, 2024
Exploring the Latest in Renal Cell Cancer Therapies with Dr. Monty Pal using an Algorithm
Mar 11, 2024
How to treat Prostate Cancer in 2024 with Dr. Rana McKay
Feb 26, 2024
Dr. Hope Rugo discusses Capivasertib FDA Approval based on CAPItello-291 Study
Feb 22, 2024
How to Treat HR+ Breast Cancer with Dr. Virginia Kaklamani | Onc Brothers
Feb 15, 2024
GU ASCO 2024 Highlights with Dr. Tian Zhang – CONTACT-02, BRCAAway, AMBASSADOR, Keynote-564
Feb 08, 2024
How to treat HER2+ Breast Cancer in 2024 with Dr. Harold Burstein
Feb 05, 2024
GI ASCO 2024 Highlights with Dr. Pamela Kunz – CheckMate 8HW, EMERALD-1, NETTER-2
Feb 01, 2024